Evidence map›Paper›PMID 33385945›Full record

ArticleEpilepsy research2021

Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicity.

Dana C Walters, Erwin E W Jansen, Gajja S Salomons, Erland Arning, Paula Ashcraft, Teodoro Bottiglieri, Jean-Baptiste Roullet, K Michael Gibson

Open access · greenAbstract read
In one paragraph

Article in Epilepsy research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Molecular docking andJournal of Taibah University Medical Sciences · 2025
    Review
  2. Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Dana C WaltersDepartment of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.
Erwin E W JansenDepartment of Clinical Chemistry, Metabolic Unit, VU University Medical Center & Amsterdam Neuroscience, Amsterdam, the Netherlands.
Gajja S SalomonsDepartment of Clinical Chemistry, Metabolic Unit, VU University Medical Center & Amsterdam Neuroscience, Amsterdam, the Netherlands.
Erland ArningBaylor Scott & White Research Institute, Institute of Metabolic Disease, Dallas, TX, USA.
Paula AshcraftBaylor Scott & White Research Institute, Institute of Metabolic Disease, Dallas, TX, USA.
Teodoro BottiglieriBaylor Scott & White Research Institute, Institute of Metabolic Disease, Dallas, TX, USA.
Jean-Baptiste RoulletDepartment of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.
K Michael GibsonDepartment of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA. Electronic address: mike.gibson@wsu.edu.
Baylor Medical Center at Garland · USWashington State University Spokane · USAmsterdam Neuroscience · NL

Funding

Rapalog Therapy in Heritable and Vigabatrin-Induced GABA Metabolic DisordersR01EY027476 · NEI · WASHINGTON STATE UNIVERSITY · PI GIBSON, K MICHAEL · 2017 to 2020
$1.7M
NEI NIH HHS R01 EY027476
6 · The paper itself

Abstract

((S)-(+)/(R)-(-)) vigabatrin (Sabril

Indexed as

Retina4-Aminobutyrate TransaminaseAnimalsAnticonvulsantsMaleMiceMice, Inbred C57BLVigabatrin4-Aminobutyrate TransaminaseAnticonvulsantsVigabatrin2-aminoadipic acidGABAIsomersRetinaVigabatrin

Identifiers

PMID33385945
PMCPMC7897276
OpenAlexW3117404763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.